Property Disposal

Oxford Instruments PLC 04 July 2007 4th July 2007 Oxford Instruments plc Property sale completed - Abingdon, UK Oxford Instruments plc, the high technology tools and systems company, is pleased to announce that it has completed the sale of its vacant property at Abingdon, UK. The property had become surplus to operating requirements following an earlier restructuring of its Analytical Businesses. At 31 March 2007 the property was held as an asset for sale with a carrying value of £5.0m. The net proceeds of the sale are £5.3m. Enquiries: Oxford Instruments plc Tel: 01865 393200 Jonathan Flint, Chief Executive Kevin Boyd, Group Finance Director Hogarth Partnership Limited Tel: 020 7357 9477 Rachel Hirst / Andrew Jaques / Ian Payne Notes to Editors Oxford Instruments plc designs, supplies and supports high-technology tools, processes and solutions with a focus on physical science, bioscience, environmental and industrial research and applications. It provides solutions needed to advance fundamental nanoscience research and its transfer into commercial nanotechnology applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 40 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. The first technology business to be spun out from Oxford University over forty years ago, Oxford Instruments is now a global company with over 1,300 staff worldwide and a listing on the London Stock Exchange (OXIG). Its objective is to be the leading provider of new generation tools and systems for the Physical Science and Bioscience sectors. This involves the combination of core technologies in areas such as low temperature and high magnetic field environments; superconductivity; Nuclear Magnetic Resonance; X-ray electron and optical based metrology, and advanced growth, deposition and etching. Our products, expertise, and ideas address global issues such as energy, environment, terrorism and health and are part of the next generation of telecommunications, energy products, environmental measures, security devices, drug discovery and medical advances. This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings